|
Peptide Therapeutics is to receive a £28m investment from Baxter of the US in exchange for a 20% stake, and the company will be renamed Acambis. 21-Sep-2000 Cantab Pharmaceuticals is in talks to acquire Peptide Therapeutics, the Cambridge-based biotechnology company, for about £80m, in order to create the largest independent vaccines group in Europe. 27-Jul-2000 Peptide Therapeutics has sold its Mimetrix drug discovery business to Medivir of Sweden for up to £6m, prompting speculation that Peptide could become a takeover target. 28-Mar-2000 Peptide Therapeutics is to cut 16 of its 90-strong workforce in Cambridge, as part of a plan to split itself in two in order to cut costs and develop neglected areas of drug discovery. 28-Sep-1999 Peptide Therapeutics is looking to sell off its drug discovery operations, in order to focus on its vaccine business. 21-Sep-1999 Peptide Therapeutics has announced an alliance with Rhone-Poulenc's Pasteur Merieux Connaught division in order to develop vaccines against viral infection. 30-Jan-1999 Peptide Therapeutics has announced a research agreement with Novartis Pharma of Switzerland for the development of protease inhibitor drugs. 05-Dec-1998 Peptide Therapeutics is planning to acquire OraVax, the US developer of vaccines, for £9m. 12-Nov-1998 Peptide Therapeutics has announced a collaboration with Eli Lilly of the US, in which they will undertake research into the disabling of harmful enzymes in the body. 06-Nov-1998 Peptide Therapeutics has awarded Pasteur Merieux OraVax of the US an exclusive option on a worldwide licence for an oral delivery anti-ulcer vaccine, and the US company will pay the full cost of development. 29-Apr-1998 Peptide Therapeutics has been given the go-ahead from the US FDA to run a series of tests on its oral typhoid vaccine, that should enable the vaccine to reach the market in 2001, two years ahead of schedule. 03-Apr-1998 Peptide Therapeutics has awarded an exclusive option on a worldwide licence for a veterinary allergy vaccine to Pfizer of the US. 06-Jan-1998 Peptide Therapeutics is to start clinical trials on an innovative allergy vaccine, having been granted a US patent. 28-May-1997 Peptide Therapeutics has reached agreement with SmithKline Beecham for the marketing of its new allergy vaccine. 11-Feb-1997 Medeva has acquired a 3% stake in Peptide Therapeutics for £3m, and the two companies are to co-operate on the development of new vaccines. 24-Jan-1997 BTG has licensed an animal allergy vaccine to Peptide Therapeutics, who is in discussions with major companies about the commercialisation of the vaccine for use with pets. 05-Nov-1996 Peptide Therapeutics expects to sign a licensing agreement with Mochida of Japan in which Mochida will test and sell Peptide products in return for royalty payments. 17-Apr-1996
|